Skip to search formSkip to main contentSkip to account menu

Tecovirimat

Known as: N-((3aR,4R,4aR,5aS,6S,6aS)-1,3-Dioxo-3,3a,4,4a,5,5a,6,6a-octahydro-4,6-ethenocyclopropa(f)isoindol-2(1H)-yl)-4-(trifluoromethyl)benzamide 
An orally available small molecule with activity against orthopoxviruses. Tecovirimat is an inhibitor of viral p37 and blocks the ability of virus… 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

ST-246

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
An antiviral for smallpox
2018
2018
Faculty Opinions recommendation of Oral tecovirimat for the treatment of smallpox.
  • S. Isaacs
  • Faculty Opinions – Post-Publication Peer Review…
  • 2018
  • Corpus ID: 80910233
2018
2018
COMPOSITION PHARMACEUTIQUE DE TECOVIRIMAT À ADMINISTRATION ORALE ET SA MÉTHODE DE PRÉPARATION
2016
2016
Preformulation study on anti-smallpox drug tecovirimat
2014
2014
Rehydratisierung von mikronisiertem tecovirimat-monohydrat
2012
2012
Determination of the equilibrium solubility of tecovirimat and its apparent oil/water partition coefficients using HPLC
Objective To determine the equilibrium solubility and oil/water apparent partition coefficients(lgP) of tecovirimat(ST-246) in a… 
2010
2010
Historical perspectives in the development of antiviral agents against poxviruses.
The poxvirus vaccinia virus (VV) served as the model virus for which the first antivirals, the thiosemicarbazones, were… 
2010
2010
Monograph: Tecovirimat for smallpox infections
2008
2008
Molecule of the month. Tecovirimat.
2008
2008
Gateways to clinical trials.
Gateways to clinical trials is a guide to the most recent trials in current literature and congresses. The data in the following… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)